CNTXVSGPCR• 12 Months (Normalized)
CNTX vs GPCR (Context Therapeutics Inc. vs Structure Therapeutics Inc.)
Showing Closing Date Range from Sep, 14, 2025 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CNTX Performance $0.35
-56.77%
Context Therapeutics Inc.
Normalized Baseline0.00%
GPCR Performance $38.44
+90.3%
Structure Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin GPCR LEADS
-147.07%
GPCR outperforming by 147.07%
CNTXGPCR
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CNTX GPCR
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | CNTX Price | CNTX Gain (%) | GPCR Price | GPCR Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $0.35 | -56.77% | $38.44 | +90.30% | -147.07% |
| Sep 11, 2026 | $0.35 | -56.90% | $38.66 | +91.39% | -148.29% |
| Sep 10, 2026 | $0.37 | -54.93% | $39.55 | +95.79% | -150.72% |
| Sep 09, 2026 | $0.37 | -54.43% | $41.23 | +104.11% | -158.54% |
| Sep 08, 2026 | $0.38 | -53.69% | $40.38 | +99.90% | -153.59% |
| Sep 04, 2026 | $0.36 | -55.42% | $47.34 | +134.36% | -189.78% |
| Sep 03, 2026 | $0.36 | -55.30% | $47.34 | +134.36% | -189.66% |
| Sep 02, 2026 | $0.36 | -55.30% | $47.80 | +136.63% | -191.93% |
| Sep 01, 2026 | $0.36 | -55.17% | $47.13 | +133.32% | -188.49% |
| Aug 31, 2026 | $0.39 | -51.97% | $45.91 | +127.28% | -179.25% |
| Aug 28, 2026 | $0.38 | -52.71% | $47.37 | +134.50% | -187.21% |
| Aug 27, 2026 | $0.42 | -48.77% | $49.22 | +143.66% | -192.43% |
| Aug 26, 2026 | $0.42 | -47.78% | $49.35 | +144.31% | -192.09% |
| Aug 25, 2026 | $0.44 | -46.43% | $49.92 | +147.13% | -193.56% |
| Aug 24, 2026 | $0.47 | -42.73% | $49.01 | +142.62% | -185.35% |
Page 1 of 17